Cargando…

A meta-analysis of the effects of β-adrenergic blockers in chronic heart failure

Adrenergic β-blockers are drugs that bind to, but do not activate β-adrenergic receptors. Instead they block the actions of β-adrenergic agonists and are used for the treatment of various diseases such as cardiac arrhythmias, angina pectoris, myocardial infarction, hypertension, headache, migraines,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiaojian, Shen, Chengwu, Zhai, Shujun, Liu, Yukun, Yue, Wen-Wei, Han, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038900/ https://www.ncbi.nlm.nih.gov/pubmed/27703506 http://dx.doi.org/10.3892/etm.2016.3657

Ejemplares similares

β1 Adrenergic Receptor Polymorphisms and Heart Failure: A Meta-Analysis on Susceptibility, Response to β-Blocker Therapy and Prognosis
por: Liu, Wen-Nan, et al.
Publicado: (2012)

Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy
por: Reddy, Sushma, et al.
Publicado: (2015)

β blockers for heart failure
por: Hoes, Arno W
Publicado: (2016)

Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease
por: Lipworth, Brian, et al.
Publicado: (2016)

Does atenolol differ from other β-adrenergic blockers?
por: Aursnes, Ivar, et al.
Publicado: (2007)

Suboptimal Dosing of β-Blockers in Chronic Heart Failure: A Missed Opportunity?
por: McGinlay, Melanie, et al.
Publicado: (2022)

β(1)-Blockers Enhance Inotropy of Endogenous Catecholamines in Chronic Heart Failure
por: Feuerstein, Thomas J., et al.
Publicado: (2021)

β-Adrenergic receptor signaling in cardiac function and heart failure
por: Madamanchi, Aasakiran
Publicado: (2007)

Beta-adrenergic receptor antagonists and chronic heart failure in children
por: Filippo, Sylvie Di
Publicado: (2007)

Chronic obstructive pulmonary disease and β‐blocker treatment in Asian patients with heart failure
por: Kubota, Yoshiaki, et al.
Publicado: (2017)

β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation—a meta-analysis
por: Xu, Tianyu, et al.
Publicado: (2019)

The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
por: Masarone, Daniele, et al.
Publicado: (2021)

Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial
por: Garcia-Lunar, Ines, et al.
Publicado: (2020)

Perioperative adrenergic response and the use of beta-blockers
por: Kim, Tae-Yop
Publicado: (2014)

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
por: Chatterjee, Saurav, et al.
Publicado: (2013)

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
Publicado: (2013)

β-AR Blockers Suppresses ER Stress in Cardiac Hypertrophy and Heart Failure
por: Ni, Li, et al.
Publicado: (2011)

T-Tubular Electrical Defects Contribute to Blunted β-Adrenergic Response in Heart Failure
por: Crocini, Claudia, et al.
Publicado: (2016)

New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging
por: de Lucia, Claudio, et al.
Publicado: (2018)

Arrhythmogenic Mechanisms in Heart Failure: Linking β-Adrenergic Stimulation, Stretch, and Calcium
por: Johnson, Daniel M., et al.
Publicado: (2018)

Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study
por: Lee, Hae-Young, et al.
Publicado: (2016)

The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury
por: Nurlu Temel, Esra, et al.
Publicado: (2023)

Treatment optimization of beta-blockers in chronic heart failure therapy
por: Niriayo, Yirga Legesse, et al.
Publicado: (2020)

Heart Failure and MEF2 Transcriptome Dynamics in Response to β-Blockers
por: Tobin, S. W., et al.
Publicado: (2017)

Meta-Analysis of the Safety and Efficacy of α-Adrenergic Blockers for Pediatric Urolithiasis in the Distal Ureter
por: Sun, Fengze, et al.
Publicado: (2022)

β-adrenergic blockade attenuates cardiac dysfunction and myofibrillar remodelling in congestive heart failure
por: Machackova, Jarmila, et al.
Publicado: (2011)

β-Adrenergic Receptor Desensitization/Down-Regulation in Heart Failure: A Friend or Foe?
por: Mahmood, Abrahim, et al.
Publicado: (2022)

Leukocyte Redistribution: Effects of Beta Blockers in Patients with Chronic Heart Failure
por: von Haehling, Stephan, et al.
Publicado: (2009)

β-Adrenergic Receptor and Insulin Resistance in the Heart
por: Mangmool, Supachoke, et al.
Publicado: (2017)

Prolonged β-adrenergic stimulation disperses ryanodine receptor clusters in cardiomyocytes and has implications for heart failure
por: Shen, Xin, et al.
Publicado: (2022)

Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure
por: Perez, Dianne M.
Publicado: (2021)

Distinct features of calcium handling and β‐adrenergic sensitivity in heart failure with preserved versus reduced ejection fraction
por: Kilfoil, Peter J., et al.
Publicado: (2020)

Can beta-adrenergic blockers be used in the treatment of COVID-19?
por: Vasanthakumar, Natesan
Publicado: (2020)

Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapy
por: Cannavo, Alessandro, et al.
Publicado: (2013)

Cardiac Adrenergic Activation in Heart Failure With Preserved Ejection Fraction: A Role for β-Blockade?
por: Bristow, Michael R., et al.
Publicado: (2022)

Regulation of Cisplatin Resistance in Lung Cancer Cells by Nicotine, BDNF, and a β-Adrenergic Receptor Blocker
por: Ray, Ravel, et al.
Publicado: (2022)

The Impact of Treatment with Beta-Blockers upon Mortality in Chronic Heart Failure Patients
por: Taneva, Borjanka, et al.
Publicado: (2016)

Effectiveness and safety of four different beta‐blockers in patients with chronic heart failure
por: Liu, Baoshan, et al.
Publicado: (2023)

Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease
por: Kubota, Yoshiaki, et al.
Publicado: (2015)

Clinical efficacy of beta1 selective adrenergic blockers in the treatment of neurocardiogenic syncope – a meta-analysis
por: Vallurupalli, Srikanth, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_b8h3c46n9eal1gvintjo58t1b8